| Dr Thomas Augustine Neal Ii, MD | |
|
1050 W Perimeter Rd, Andrews Afb, MD 20762-6601 | |
| (240) 857-4530 | |
| Not Available |
| Full Name | Dr Thomas Augustine Neal Ii |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 1050 W Perimeter Rd, Andrews Afb, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255581021 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083A0100X | Preventive Medicine - Aerospace Medicine | 0101043280 (Virginia) | Secondary |
| 2083X0100X | Preventive Medicine - Occupational Medicine | 0101043280 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Augustine Neal Ii, MD 1050 W Perimeter Rd, Andrews Afb, MD 20762-6601 Ph: (240) 857-4530 | Dr Thomas Augustine Neal Ii, MD 1050 W Perimeter Rd, Andrews Afb, MD 20762-6601 Ph: (240) 857-4530 |
News Archive
To cut medical-malpractice costs, five New York City hospitals have agreed to a pilot program to divulge medical mistakes early, offer settlements quickly and use special state 'health courts,' where judges will help negotiate agreements before cases go to trial. The program, funded for three years with $3 million from the federal government, aims to cut the $1.4 billion spent annually in New York State on medical-malpractice premiums, hospital and state officials say.
A new study, presented today at the AATS 101st Annual Meeting, shows that non-invasive cell-free DNA tests can reduce the need for regular surveillance biopsies to detect early rejection in heart transplant patients. The study was the first of its kind to be performed on both adult and pediatric patients.
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, has announced an agreement to provide access to Martindale: The Complete Drug Reference as part of premium subscriptions to its flagship drug reference, Facts & Comparisons® eAnswers.
In a study published online today in the American Journal of Obstetrics & Gynecology, researchers from the Sequenom Center for Molecular Medicine confirmed that DNA sequencing of maternal blood plasma could accurately detect trisomy 21.
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved XALKORI (crizotinib) capsules, the first-ever therapy targeting anaplastic lymphoma kinase (ALK), for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is ALK-positive as detected by an FDA-approved test.
› Verified 9 days ago
Terry Lane Haske, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1050 W Perimeter Rd, 79 Amds, Andrews Afb, MD 20762 Phone: 240-857-5972 | |
Dr. James Roald Bennion, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 79 Mdg Chief, Medical Staff, 1050 West Perimeter Rd, Andrews Afb, MD 20762 Phone: 240-857-8811 | |
Dr. Jodi Lynn Volmert, DO, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1075 W. Perimeter Rd, 79 Amds/sgpf, Andrews Afb, MD 20762 Phone: 240-857-5282 Fax: 240-857-3073 |